Less than a month after the US Food and Drug Administration said a TV advertisement for Novo Nordisk A/S’ Wegovy weight-loss ...

Not long after Novo Nordisk received an untitled letter from the FDA disputing certain elements of the first TV spot for its ...

Novo Nordisk (NVO) stock is in focus as the firm gets FDA scrutiny over an Ozempic TV ad, the second warning it received for ...

The FDA sent a warning letter this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, ...

This time, the FDA took issue with how the ad positioned Ozempic as superior to other GLP-1s, taking aim at small details from comedic devices to the color of shirts.

The ads, it seems, are real. Serena Williams is jumping on the GLP-1 trend — and the results speak for themselves.

EXCLUSIVE: Americans who suffered devastating side effects after taking GLP-1 drugs Ozempic and Wegovy tell Rhian Lubin why they are suing. “If someone would have told me ... a drug I was taking could ...

The FDA wrote a letter on February 26 saying that the ad "There's Only One Ozempic" lied about the permitted uses of the injectable medicine and, without enough proof, asserted it was better than ...

The U.S. Food and Drug Administration (FDA) has issued a warning to Danish pharmaceutical giant Novo Nordisk regarding a consumer advertisement for its widely used diabetes drug, Ozempic. According to ...

Even when many have spoken about the side effects it can have, the drug continues to be in high demand. And now, we have something called microdosing Ozempic ...

Add Yahoo as a preferred source to see more of our stories on Google. Justin Long and John Hodgman reunited for an Ozempic commercial, of all things, and people have a lot of feelings about it. In the ...

Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are ...